216 related articles for article (PubMed ID: 36284286)
1. Parathyroid carcinoma during pregnancy: a novel pathogenic CDC73 mutation - a case report.
Dematapitiya C; Perera C; Pathmanathan S; Subasinghe V; Anandagoda G; Dissanayaka V; Wijenayake U; Dissanayake P; Gamage K; Wijewickrama P; Sumanatilleke M
BMC Endocr Disord; 2022 Oct; 22(1):259. PubMed ID: 36284286
[TBL] [Abstract][Full Text] [Related]
2. Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report.
Rutledge S; Harrison M; O'Connell M; O'Dwyer T; Byrne MM
J Med Case Rep; 2016 Oct; 10(1):286. PubMed ID: 27756436
[TBL] [Abstract][Full Text] [Related]
3. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract][Full Text] [Related]
4. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
5. Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma.
Gulcelik NE; Bozkurt F; Tezel GG; Kaynaroglu V; Erbas T
Endocrine; 2009 Apr; 35(2):147-50. PubMed ID: 19116787
[TBL] [Abstract][Full Text] [Related]
6. Normocalcemic primary hyperparathyroidism: long-term follow-up associated with multiple adenomas.
Pimentel L; Portela S; Loureiro A; Bandeira F
Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):583-6. PubMed ID: 25166050
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Cancer in the Pediatric Patient.
Davidson JT; Lam CG; McGee RB; Bahrami A; Diaz-Thomas A
J Pediatr Hematol Oncol; 2016 Jan; 38(1):32-7. PubMed ID: 26650250
[TBL] [Abstract][Full Text] [Related]
8. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature.
Serrano-Gonzalez M; Shay S; Austin J; Maceri DR; Pitukcheewanont P
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1005-12. PubMed ID: 27544721
[TBL] [Abstract][Full Text] [Related]
9. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case.
Ito Y; Iwase H; Tanaka H; Yuasa H; Kureyama Y; Yamashita H; Toyama T; Kimura M; Kobayashi S
Surg Today; 2001; 31(10):895-8. PubMed ID: 11759885
[TBL] [Abstract][Full Text] [Related]
10. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
11. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
[TBL] [Abstract][Full Text] [Related]
12. Intrathyroidal parathyroid carcinoma as cause of hypercalcemia and pitfall of localization techniques: clinical and biologic features.
Foppiani L; Del Monte P; Sartini G; Arlandini A; Quilici P; Bandelloni R; Marugo A; Bernasconi D
Endocr Pract; 2007; 13(2):176-81. PubMed ID: 17490933
[TBL] [Abstract][Full Text] [Related]
13. Persistent Primary Hyperparathyroidism Secondary to an Ectopic Mediastinal Adenoma in a Young Adult: A Case Report.
Nievera KH; Alba R
J ASEAN Fed Endocr Soc; 2023; 38(2):145-148. PubMed ID: 38045675
[TBL] [Abstract][Full Text] [Related]
14. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
[TBL] [Abstract][Full Text] [Related]
16. Secondary hyperparathyroidism after removal of a parathyroid adenoma.
Jiménez-Montero JG; Lobo-Hernández E; Picado-Larios A; Molina MA
Endocr Pract; 2002; 8(6):429-32. PubMed ID: 15260008
[TBL] [Abstract][Full Text] [Related]
17. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
18. Humoral hypercalcemia of pregnancy treated with bisphosphonates.
Koren R; Neeman O; Koren S; Benbassat CA
Arch Endocrinol Metab; 2018 Feb; 62(1):125-128. PubMed ID: 29694631
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Parathyroid Adenomas with New Ultrasound Imaging Modalities.
Azizi G; Mayo ML; Keller J; Farrell J; Malchoff C
VideoEndocrinology; 2019; 6(4):. PubMed ID: 32025531
[TBL] [Abstract][Full Text] [Related]
20. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
